1. Medtech Insight
  2. >>Geography
  3. >>Europe

swissdamed Database Needs A Few More Months With UDI Model Now Underway

Swiss modular database taking shape now using Swissmedic Cloud

 
• By Ashley Yeo

Switzerland has been developing a national medical devices database to mirror Eudamed, the EU version that has excluded participation by Swiss companies since the failure of the federal council and European Commission to update the MRA for devices.

By Maxim Gaigul Royalty-free stock illustration ID: 476308105 Computer keyboard, close-up button of the flag of Switzerland. 3D render of a laptop keyboard

Qualitative improvements have been made to swissdamed, the IT system to support application of the Swiss regulations on medical devices and in vitro diagnostic medical devices, leading to go-live dates being deferred by a few months.

Swissdamed − the Swiss Database on Medical Devices – will enable the regulator, Swissmedic, to directly register economic operators using...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Switzerland

More from Europe

Ultromics Wins $55M, The Key To Success: Diagnosing Diseases With Available Treatment

 
• By Natasha Barrow

Ultromics has secured $55m in Series C funding to advance its AI tool, EchoGo, which detects undiagnosed heart failure. The company's focus on diseases with available treatments resonated with investors.

Why EU Notified Bodies Need To Alter The Way They Work

 
• By Amanda Maxwell

Without change, the implementation of the MDR and IVDR could hit another wall.

UK MHRA Takes Stock, Seeks CMSO And Reveals Device Innovation Early Access Thinking

 
• By Ashley Yeo

Evolution of the MHRA and its offering to medtechs continues, with the hunt for a visionary chief medical and scientific officer and release of outline plans on early access to innovative devices, building on IDAP learnings.